Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. MRNA
3. EL
4. MRK
5. BILL
6. RARE
7. LOW
8. DE
9. UBER
10. NTES

Go back to Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model
(NASDAQ: KPRX) Delayed: 2.60 --0 (-0%)
Previous Close $2.60    52 Week High $ 
Open $2.60    52 Week Low $ 
Day High $2.60    P/E N/A 
Day Low $2.60    EPS $ 
Volume 13